LASA SUPERGENERICS
|
LASA SUPERGENERICS Last 5 Year Balance Sheet History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹41 Cr | ₹41 Cr |
| Equity - Authorised | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹50 Cr | ₹50 Cr |
| Equity - Issued | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹41 Cr | ₹41 Cr |
| Equity Paid Up | ₹50 Cr | ₹50 Cr | ₹50 Cr | ₹41 Cr | ₹41 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹47 Cr | ₹68 Cr | ₹108 Cr | ₹118 Cr | ₹101 Cr |
| Securities Premium | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr |
| Capital Reserves | ₹52 Cr | ₹52 Cr | ₹52 Cr | ₹56 Cr | ₹56 Cr |
| Profit & Loss Account Balance | ₹-47 Cr | ₹-25 Cr | ₹14 Cr | ₹21 Cr | ₹3.28 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | - | - | - | - | - |
| Reserve excluding Revaluation Reserve | ₹47 Cr | ₹68 Cr | ₹108 Cr | ₹118 Cr | ₹101 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹97 Cr | ₹118 Cr | ₹158 Cr | ₹159 Cr | ₹141 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | ₹14 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | ₹14 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | ₹0.14 Cr |
| Unsecured Loans | - | - | - | - | ₹0.44 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | ₹0.43 Cr |
| Other Unsecured Loan | - | - | - | - | ₹0.01 Cr |
| Deferred Tax Assets / Liabilities | ₹4.85 Cr | ₹2.24 Cr | ₹5.91 Cr | ₹7.82 Cr | ₹-3.17 Cr |
| Deferred Tax Assets | ₹0.37 Cr | ₹0.34 Cr | ₹0.32 Cr | ₹0.27 Cr | ₹16 Cr |
| Deferred Tax Liability | ₹5.21 Cr | ₹2.57 Cr | ₹6.23 Cr | ₹8.10 Cr | ₹13 Cr |
| Other Long Term Liabilities | - | - | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹0.47 Cr | ₹0.61 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.46 Cr |
| Total Non-Current Liabilities | ₹5.32 Cr | ₹2.84 Cr | ₹6.54 Cr | ₹8.41 Cr | ₹11 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹14 Cr | ₹9.43 Cr | ₹17 Cr | ₹13 Cr | ₹34 Cr |
| Sundry Creditors | ₹14 Cr | ₹9.43 Cr | ₹17 Cr | ₹13 Cr | ₹34 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹17 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹0.02 Cr | ₹0.11 Cr | ₹0.18 Cr | ₹0.04 Cr | ₹0.93 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹16 Cr |
| Short Term Borrowings | - | - | - | - | ₹20 Cr |
| Secured ST Loans repayable on Demands | - | - | - | - | ₹20 Cr |
| Working Capital Loans- Sec | - | - | - | - | ₹20 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | ₹-20 Cr |
| Short Term Provisions | ₹11 Cr | ₹10 Cr | ₹6.02 Cr | ₹6.34 Cr | ₹4.97 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | - | - | - | ₹1.98 Cr | ₹0.91 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹11 Cr | ₹10 Cr | ₹6.02 Cr | ₹4.36 Cr | ₹4.06 Cr |
| Total Current Liabilities | ₹49 Cr | ₹43 Cr | ₹45 Cr | ₹41 Cr | ₹76 Cr |
| Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
| ASSETS | |||||
| Gross Block | ₹230 Cr | ₹229 Cr | ₹234 Cr | ₹226 Cr | ₹220 Cr |
| Less: Accumulated Depreciation | ₹120 Cr | ₹110 Cr | ₹96 Cr | ₹83 Cr | ₹67 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹110 Cr | ₹119 Cr | ₹137 Cr | ₹143 Cr | ₹152 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹2.51 Cr | ₹4.65 Cr | ₹4.58 Cr | - | - |
| Non Current Investments | - | ₹0.39 Cr | ₹0.38 Cr | - | - |
| Long Term Investment | - | ₹0.39 Cr | ₹0.38 Cr | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | ₹0.39 Cr | ₹0.38 Cr | - | - |
| Long Term Loans & Advances | ₹0.71 Cr | ₹0.59 Cr | ₹0.63 Cr | ₹0.59 Cr | ₹0.75 Cr |
| Other Non Current Assets | - | ₹0.05 Cr | - | - | - |
| Total Non-Current Assets | ₹113 Cr | ₹125 Cr | ₹143 Cr | ₹144 Cr | ₹153 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹19 Cr | ₹14 Cr | ₹11 Cr | ₹17 Cr | ₹26 Cr |
| Raw Materials | ₹7.29 Cr | ₹6.21 Cr | ₹7.82 Cr | ₹11 Cr | ₹10 Cr |
| Work-in Progress | ₹5.46 Cr | ₹1.90 Cr | ₹3.15 Cr | ₹1.75 Cr | ₹8.78 Cr |
| Finished Goods | ₹6.29 Cr | ₹5.79 Cr | ₹0.54 Cr | ₹4.21 Cr | ₹7.41 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | - | - | - | - | - |
| Sundry Debtors | ₹3.59 Cr | ₹2.48 Cr | ₹19 Cr | ₹15 Cr | ₹21 Cr |
| Debtors more than Six months | ₹0.95 Cr | ₹0.55 Cr | ₹0.64 Cr | ₹3.14 Cr | - |
| Debtors Others | ₹3.25 Cr | ₹2.44 Cr | ₹18 Cr | ₹12 Cr | ₹21 Cr |
| Cash and Bank | ₹1.50 Cr | ₹2.39 Cr | ₹17 Cr | ₹4.40 Cr | ₹6.06 Cr |
| Cash in hand | ₹0.10 Cr | ₹0.05 Cr | ₹0.16 Cr | ₹0.47 Cr | ₹0.56 Cr |
| Balances at Bank | ₹1.40 Cr | ₹0.96 Cr | ₹17 Cr | ₹3.94 Cr | ₹5.50 Cr |
| Other cash and bank balances | - | ₹1.38 Cr | - | - | - |
| Other Current Assets | ₹0.06 Cr | ₹0.01 Cr | ₹0.09 Cr | ₹0.01 Cr | ₹0.10 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹0.06 Cr | ₹0.01 Cr | ₹0.09 Cr | ₹0.01 Cr | ₹0.10 Cr |
| Other current_assets | - | - | - | - | - |
| Short Term Loans and Advances | ₹14 Cr | ₹20 Cr | ₹19 Cr | ₹28 Cr | ₹23 Cr |
| Advances recoverable in cash or in kind | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹26 Cr | ₹22 Cr |
| Advance income tax and TDS | - | - | ₹0.09 Cr | ₹-0.05 Cr | ₹-0.04 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹-2.80 Cr | ₹4.70 Cr | ₹2.46 Cr | ₹1.75 Cr | ₹0.93 Cr |
| Total Current Assets | ₹38 Cr | ₹39 Cr | ₹66 Cr | ₹64 Cr | ₹76 Cr |
| Net Current Assets (Including Current Investments) | ₹-11 Cr | ₹-3.51 Cr | ₹22 Cr | ₹24 Cr | ₹-0.05 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
| Contingent Liabilities | - | - | - | - | - |
| Total Debt | ₹22 Cr | ₹22 Cr | ₹20 Cr | ₹19 Cr | ₹48 Cr |
| Book Value | 19.30 | 23.61 | 31.51 | 39.07 | 34.78 |
| Adjusted Book Value | 19.30 | 23.61 | 31.51 | 39.07 | 34.78 |
Compare Balance Sheet of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹55.2 Cr | 7.3% | -14.7% | -60.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 7.3% |
-14.7% |
-60.2% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses